Sarcopenia with glucose-lowering drugs

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2021年 / 1875卷 / 1期
关键词：
D O I：
10.1007/s40278-021-02928-9
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：12 / 12
相关论文
共 50 条
  • [1] Comparison of glucose-lowering drugs
    Kang, Seema
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2016, 4 (09): : 736 - 736
  • [2] Pharmacogenetics of novel glucose-lowering drugs
    Wolfgang Rathmann
    Brenda Bongaerts
    [J]. Diabetologia, 2021, 64 : 1201 - 1212
  • [3] Pharmacogenetics of novel glucose-lowering drugs
    Rathmann, Wolfgang
    Bongaerts, Brenda
    [J]. DIABETOLOGIA, 2021, 64 (06) : 1201 - 1212
  • [4] The Impact of Glucose-Lowering Drugs on Sarcopenia in Type 2 Diabetes: Current Evidence and Underlying Mechanisms
    Massimino, Elena
    Izzo, Anna
    Riccardi, Gabriele
    Della Pepa, Giuseppe
    [J]. CELLS, 2021, 10 (08)
  • [5] Influence of Telmisartan on the Metabolism of Glucose-Lowering Drugs
    Li, Jian-Hui
    [J]. LATIN AMERICAN JOURNAL OF PHARMACY, 2018, 37 (03): : 484 - 488
  • [6] Perioperative Management of Glucose-lowering Drugs: Comment
    Gregory, Stephen Harrison
    [J]. ANESTHESIOLOGY, 2021, 134 (02) : 349 - 349
  • [7] Cardiovascular safety concerns of glucose-lowering drugs
    Scholze J.
    [J]. MMW - Fortschritte der Medizin, 2017, 159 (1) : 62 - 66
  • [8] Glucose-lowering drugs: balancing risks and benefits
    不详
    [J]. LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (09): : 669 - 669
  • [9] Cardiovascular Outcome Trials with Glucose-Lowering Drugs
    Tina K. Thethi
    Anika Bilal
    Richard E. Pratley
    [J]. Current Cardiology Reports, 2021, 23
  • [10] Cardiovascular Outcome Trials with Glucose-Lowering Drugs
    Thethi, Tina K.
    Bilal, Anika
    Pratley, Richard E.
    [J]. CURRENT CARDIOLOGY REPORTS, 2021, 23 (07)
12345